Ozempic and related GLP-1 drugs have taken Europe and North America by storm and have quickly become the darling of the ...

Over the past three decades, there has been a startling increase in the prevalence of obesity across the U.S., at least ...

For patients with type 2 diabetes mellitus (T2DM), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with ...

Altimmune’s lead drug Pemvidutide demonstrates significant progress in obesity and liver health. See why ALT stock is a ...